2025中国TCE赛道全景:百余管线竞逐,谁将领跑免疫治疗新纪元?

ITBEAR科技资讯
Nov 24, 2025

近年来,T细胞衔接器(TCE)逐渐成为全球医药研发领域的焦点,尤其是在肿瘤治疗和自身免疫疾病领域展现出巨大潜力。自2024年下半年起,跨国药企(MNC)对TCE技术的关注度显著提升,一系列重磅交易接连落地,其出海势头甚至不亚于当年抗体偶联药物(ADC)的盛况。TCE是一种特殊的双特异性抗体,其设计原理是通过一端或两端连接肿瘤相关抗原(TAA)来定位肿瘤细胞,另一端则连接T细胞的CD3表位,从而激活...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10